Karin Garre
Director/Board Member chez EXPRES2ION BIOTECH HOLDING AB
Profil
Karin Garre is an Independent Director at Expres2ion Biotech Holding AB.
She is also a Director at Cervello A.
Previously, she served as the General Manager at Symphogen A.
Before that, she was the Chief Executive Officer at K:2.
Holding ApS.
She also held the position of Chairman at NTG Nordic Transport Group A from 2013 to 2018.
Additionally, she has experience as a Director at StemCare A, StemCare Danmark A, and Lægernes Test Center A.
Dr. Garre obtained her doctorate degree from the University of Copenhagen in 1983.
Postes actifs de Karin Garre
| Sociétés | Poste | Début |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Director/Board Member | 26/05/2021 |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 05/06/2020 |
| Cervello A/S | Director/Board Member | - |
Anciens postes connus de Karin Garre
| Sociétés | Poste | Fin |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Chairman | 14/09/2018 |
| Lægernes Test Center A/S | Director/Board Member | - |
| StemCare Danmark A/S | Director/Board Member | - |
StemCare A/S
 StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Director/Board Member | - |
| K:2 Holding ApS | Chief Executive Officer | - |
Formation de Karin Garre
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Entreprise privées | 6 |
|---|---|
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
StemCare A/S
StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Health Technology |
| StemCare Danmark A/S | |
| K:2 Holding ApS | |
| Lægernes Test Center A/S | |
| Cervello A/S |
